• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHS2101047 贝米肝素钠注射液 bemiparin sodium Injection Chemical Drugs(5.1) Import Drug Application 2021-09-01 Laboratorios Farmacéuticos ROVI;ROVI Pharma Industrial Services S.A view
JTS2400118 肝素钠 1000IU/ml 溶液(Heparin for analysis 1000IU/mL) Heparin Sodium Active ingredient Biological Products Disposable Import Drug Application 2024-09-28 Novo Nordisk (China) Pharmaceuticals Co Ltd;Pharmaskan;Novo Nordisk A/S view
JTH2100542 肝素钠 Heparin Sodium Active ingredient Chemical Drugs Disposable Import Drug Application 2021-06-15 Shenzhen Techdow Pharmaceutical Co Ltd view
JTH2200165 肝素钠 1000IU/ml 溶液 Heparin Sodium Active ingredient Chemical Drugs Disposable Import Drug Application 2022-08-25 Novo Nordisk (China) Pharmaceuticals Co Ltd;Pharmaskan;Novo Nordisk A/S view
CYHB2302044 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2023-09-11 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
B20000117 达肝素钠注射液 dalteparin sodium Injection Chemical Drugs Import Drug Application 2000-01-01 view
JYHB2500313 复方肝素钠尿囊素凝胶 Gel Chemical Drugs Supplementary Application 2025-06-12 Merz Pharmaceuticals GmbH;Merz Pharma Gmbh & Co KGaA view
JYHB2200513 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-09-17 Sanofi-Aventis France;Sanofi Winthrop Industrie view
JYHZ2400026 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs License Renew 2024-01-25 Sanofi-Aventis France;Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie view
JYHZ2400353 复方肝素钠尿囊素凝胶 Gel Chemical Drugs License Renew 2024-12-27 Zhejiang Medical Technology Development Co Ltd;Merz Pharmaceuticals GmbH;Merz Pharma Gmbh & Co KGaA view
JYHB2200134 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-03-15 Sanofi-Aventis France;Sanofi Winthrop Industrie view
CYHB2200140 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(原6) Supplementary Application 2022-01-17 Shenzhen Techdow Pharmaceutical Co Ltd view
CYHB2302366 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(4) Supplementary Application 2023-10-27 Cisen Pharmaceutical Co Ltd view
JYHB2200130 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-03-15 Sanofi-Aventis France;Sanofi Winthrop Industrie view
CYHB2400324 肝素钠封管注射液 Heparin Sodium Injection Chemical Drugs Supplementary Application 2024-03-01 Changzhou Qianhong Biopharma Co Ltd view
CYHB2300615 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(4) Supplementary Application 2023-03-24 Suzhou Erye Pharmaceutical Co Ltd view
JTS2300081 肝素钠 1000IU/ml 溶液 (Heparin for analysis 1000IU/mL) Heparin Sodium Active ingredient Biological Products Disposable Import Drug Application 2023-12-14 Novo Nordisk (China) Pharmaceuticals Co Ltd;Pharmaskan;Novo Nordisk A/S view
JYHB2200128 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-03-15 Sanofi-Aventis France;Sanofi Winthrop Industrie view
CYHB2400559 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs Supplementary Application 2024-04-27 Shenzhen Techdow Pharmaceutical Co Ltd;Hangzhou Ausia Biological Technology Company Ltd view
JYHB2200202 依诺肝素钠注射液 enoxaparin sodium Injection Chemical Drugs(5.1) Supplementary Application 2022-04-12 Sanofi-Aventis France;Sanofi Winthrop Industrie view